Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02245282 · ClinicalTrials.gov registry record
Contrast Enhanced MRI of the Prostate
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- 14
- Enrollment target
NCT02245282 is a clinical trial that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 14 participants.
The verdict
NCT02245282 has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
Prostate cancer detection and disease progression monitoring relies on systematic multi-core biopsies. Minimal invasive imaging capacities for lesion targeting and monitoring are badly needed. The purpose of this study is to determine if a new MRI technique can identify and monitor prostate disease progression. If so biopsy core number can be reduced to as small as one, and frequency for biopsy repeat can be reduced. The new technique is about a new way of analyzing the pictures taken as part of prostate MRI exam. This part is called dynamic contrast-enhanced MRI. It involves an injection of contrast reagent (or dye) through the arm vein during a time period when prostate MRI pictures are continuously taken.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-02-10 |
| Est. Completion | 2018-12-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02245282
The ClinicalTrials.gov registry entry for NCT02245282 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02245282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02245282 about?
NCT02245282 is a clinical study titled "Contrast Enhanced MRI of the Prostate". Prostate cancer detection and disease progression monitoring relies on systematic multi-core biopsies. Minimal invasive imaging capacities for lesion targeting and monitoring are badly needed. The purpose of this study is to determine if a new MRI technique can identify and monitor prostate disease ...
What is the current status of trial NCT02245282?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2017-02-10. Estimated completion is 2018-12-12.
Who is sponsoring clinical trial NCT02245282?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.